» Articles » PMID: 34393685

Diallyl Disulfide Attenuates Ionizing Radiation-Induced Migration and Invasion by Suppressing Nrf2 Signaling in Non-small-Cell Lung Cancer

Overview
Journal Dose Response
Publisher Sage Publications
Date 2021 Aug 16
PMID 34393685
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-associated deaths. Radiotherapy remains the primary treatment method for NSCLC. Despite great advances in radiotherapy techniques and modalities, recurrence and resistance still limit therapeutic success, even low-dose ionizing radiation (IR) can induce the migration and invasion. Diallyl disulfide (DADS), a bioactive component extracted from garlic, exhibits a wide spectrum of biological activities including antitumor effects. However, the effect of DADS on IR-induced migration and invasion remains unclear. The present study reported that IR significantly promoted the migration and invasion of A549 cells. Pretreatment with 40 μM DADS enhanced the radiosensitivity of A549 cells and attenuated IR-induced migration and invasion. In addition, 40 μM DADS inhibited migration-related protein matrix metalloproteinase-2 and 9 (MMP-2/9) expression and suppressed IR-aggravated EMT by the upregulation of the epithelial marker, E-cadherin, and downregulation of the mesenchymal marker, N-cadherin, in A549 cells. Furthermore, DADS was found to inhibit the activation of Nrf2 signaling. Based on our previous results that knockdown of Nrf2 by siRNA suppressed IR-induced migration and invasion in A549 cells, we speculated that DADS attenuated IR-induced migration and invasion by suppressing the activation of Nrf2 signaling in A549 cells.

Citing Articles

Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer.

Sun Y, Gao H, Guo P, Sun N, Peng C, Cheng Z Cancer Innov. 2024; 3(4):e122.

PMID: 38948253 PMC: 11212315. DOI: 10.1002/cai2.122.


Clobetasol propionate, a Nrf-2 inhibitor, sensitizes human lung cancer cells to radiation-induced killing via mitochondrial ROS-dependent ferroptosis.

Rai A, Patwardhan R, Jayakumar S, Pachpatil P, Das D, Panigrahi G Acta Pharmacol Sin. 2024; 45(7):1506-1519.

PMID: 38480835 PMC: 11192725. DOI: 10.1038/s41401-024-01233-8.


Diallyl Disulfide: A Bioactive Garlic Compound with Anticancer Potential.

Mitra S, Das R, Emran T, Labib R, Noor-E-Tabassum , Islam F Front Pharmacol. 2022; 13:943967.

PMID: 36071845 PMC: 9441672. DOI: 10.3389/fphar.2022.943967.


The Impact of Catalpol on Proliferation, Apoptosis, Migration, and Oxidative Stress of Lung Cancer Cells Based on Nrf2/ARE Signaling.

Wang H, Wu J, Fan H, Ji Y, Han C, Li C Biomed Res Int. 2022; 2022:5621341.

PMID: 35898682 PMC: 9313965. DOI: 10.1155/2022/5621341.


Investigation on the incidence and risk factors of lung cancer among Chinese hospital employees.

Chen Z, Chen Z, Kang J, Chu X, Fu R, Zhang J Thorac Cancer. 2022; 13(15):2210-2222.

PMID: 35818719 PMC: 9346177. DOI: 10.1111/1759-7714.14549.


References
1.
Blyth B, Cole A, MacManus M, Martin O . Radiation therapy-induced metastasis: radiobiology and clinical implications. Clin Exp Metastasis. 2017; 35(4):223-236. DOI: 10.1007/s10585-017-9867-5. View

2.
Hui C, Jun W, Ya L, Ming X . Effect of Allium sativum (garlic) diallyl disulfide (DADS) on human non-small cell lung carcinoma H1299 cells. Trop Biomed. 2008; 25(1):37-45. View

3.
Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, Nakayama K . Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet. 2005; 116(5):354-60. DOI: 10.1007/s00439-004-1162-2. View

4.
Su J, Zhou Y, Pan Z, Shi L, Yang J, Liao A . Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer. Sci Rep. 2017; 7:45624. PMC: 5372356. DOI: 10.1038/srep45624. View

5.
Zhang L, Wang N, Zhou S, Ye W, Jing G, Zhang M . Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. J Exp Clin Cancer Res. 2012; 31:66. PMC: 3502506. DOI: 10.1186/1756-9966-31-66. View